Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene. - Wikidata - wikimedia - TriplyDB

Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene.

Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene.

http://www.wikidata.org/entity/Q34800558

about

FOXO3 growth inhibition of colonic cells is dependent on intraepithelial lipid droplet density The autophagy-related gene 14 (Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion.Nicotinamide ameliorates palmitate-induced ER stress in hepatocytes via cAMP/PKA/CREB pathway-dependent Sirt1 upregulation Adipose tissue NAD+ biology in obesity and insulin resistance: From mechanism to therapy The ways and means that fine tune Sirt1 activity.Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.Nicotinamide phosphoribosyltransferase may be involved in age-related brain diseases.Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis.Sirtuin 1 signaling and alcoholic fatty liver disease.A mutant allele encoding DNA binding-deficient FoxO1 differentially regulates hepatic glucose and lipid metabolism The diabetes gene Zfp69 modulates hepatic insulin sensitivity in mice.The new biology of diabetes.Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration Sirtuin biology and relevance to diabetes treatment.Sirtuin 1 is a key regulator of the interleukin-12 p70/interleukin-23 balance in human dendritic cells.SIRT1 and energy metabolism.Wnt/β-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3.Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6 FoxO3 transcription factor and Sirt6 deacetylase regulate low density lipoprotein (LDL)-cholesterol homeostasis via control of the proprotein convertase subtilisin/kexin type 9 (Pcsk9) gene expression The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing.Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease.Regulation of FOXO3 by phosphorylation and methylation in hepatitis C virus infection and alcohol exposure.Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice.FOXO transcription factors protect against the diet-induced fatty liver disease.Dissociating fatty liver and diabetes Forkhead box class O transcription factors in liver function and disease Sirtuin and metabolic kidney disease.Physiological and pathophysiological roles of NAMPT and NAD metabolism.Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma.Nicotinamide protects hepatocytes against palmitate-induced lipotoxicity via SIRT1-dependent autophagy induction.Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities.Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability.Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice.Efficacy of statins on sirtuin 1 and endothelial nitric oxide synthase expression: the role of sirtuin 1 gene variants in human coronary atherosclerosis.Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing.Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice.

P2860

Q28384062-EAB6A0CC-6389-4460-A581-A3FD9E80DEB7 Q28512608-504B0E3F-0643-4476-AC57-1BC373EC3D5B Q33721511-83648BBE-FA8D-4FBD-A3D5-1B2740A0C39B Q33731432-2B8008FB-BBC8-4BAA-B1CF-FC4AE6A4F7BA Q33791807-E296562C-51FC-4BE1-802F-C3E8ADE9570A Q33914710-84D6948F-76E4-411E-A4AD-3F135E316174 Q34339449-162CA507-D9EB-4E08-ACE0-1F93636A60FF Q34446797-99D6EC19-E4D0-4AAF-AAAE-6047C973465E Q34981792-BFFF16F5-9587-4A6E-9E63-D086F40B6A64 Q35513589-0C9EEF5B-0927-48B7-AB3A-59DD73F1D95B Q35630807-7F414A51-8CA9-40B1-9FDB-9BE7B05F8A63 Q36065495-DEA32E20-B8AD-418C-A958-87352ED18108 Q36113537-CB49BB3D-F032-4EE2-8345-0DA84D55B1D8 Q36139803-178D06D5-0F60-46CC-9B4B-7557F5F16A7E Q36281133-217E9EA0-B40B-4323-86C2-C36EC9EE74CB Q36318922-27A1CEC2-ECB7-47E5-BC6F-43992E30F01C Q36479802-97EE8FB0-957D-4529-972F-9ED2700CFF0C Q36928964-684F87EC-414C-4B70-9D22-02F50AEEDE94 Q37163041-0F9DF178-773E-46C8-B311-47E6D3320347 Q37226067-E5769AB8-A626-40A3-B6DF-4D7D3D32EA07 Q37285835-8294DFB5-D1ED-477E-AC61-C5D056307791 Q37333482-334225CE-B8DF-4C8A-BB15-BF6B3E42F7CD Q37351122-FAB92AAB-44D5-469F-BFF5-3582F43229D6 Q37498674-A2984118-3DBD-4319-B6BC-7D12C7BE01C1 Q37704641-ADA2FB5E-95BA-47DF-AC1F-44AFC27EFF91 Q38050214-3542B61D-17A5-4E6B-B201-3AF2B9436D1C Q38121578-D5E225FE-8EB9-4CDA-8568-C4ADDD9DD176 Q38530302-26619AB3-5EE7-47C3-9A73-C4234F6D2C10 Q38555243-3EDE2617-4CEA-4061-AEAD-19DCE31166ED Q38666646-0E552099-71A0-4F39-B1FC-4F9CF6A29C80 Q38703608-8CE2432D-33D7-4BD3-895B-008CFFB31424 Q38803521-129CFE5E-DF8D-4785-8A3B-CB36506B0315 Q38836121-A37C787B-CF44-426E-92BB-F9339DEAB1B7 Q38859044-047EA71D-0746-47F0-886D-8DE8BE78E658 Q38925481-2D15650E-177B-45B0-88BA-620C6B97B56A Q39129297-33DB1974-2D6C-4092-8893-950BEF866749 Q40041201-D7F1589F-3197-4472-B7DC-30816BF32A42 Q41591129-CDDC9878-00E9-4F0B-B74C-AD638DA34DA2 Q41909845-ED53EBD9-060A-42BB-9BA9-D8303ED120C7 Q42056919-21BB5DC7-4FD3-44FC-A2EC-05C31F774717

P2860

Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene.

http://www.wikidata.org/entity/Q34800558

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Hepatic FoxOs regulate lipid m ...... hosphoribosyltransferase gene.

@ast

Hepatic FoxOs regulate lipid m ...... hosphoribosyltransferase gene.

@en

Hepatic FoxOs regulate lipid m ...... hosphoribosyltransferase gene.

@nl

type

label

Hepatic FoxOs regulate lipid m ...... hosphoribosyltransferase gene.

@ast

Hepatic FoxOs regulate lipid m ...... hosphoribosyltransferase gene.

@en

Hepatic FoxOs regulate lipid m ...... hosphoribosyltransferase gene.

@nl

prefLabel

Hepatic FoxOs regulate lipid m ...... hosphoribosyltransferase gene.

@ast

Hepatic FoxOs regulate lipid m ...... hosphoribosyltransferase gene.

@en

Hepatic FoxOs regulate lipid m ...... hosphoribosyltransferase gene.

@nl

P1433

Q34800558-D5E90E9E-DC1A-47E1-8E64-0DDCBB9847F2

P1476

Q34800558-50A66353-C309-4DD5-90B9-92F4C0D0AD88

P2093

Q34800558-47396369-F72E-4F9C-B6AF-14737ABCC325

Q34800558-68DB6667-4CFD-4CE6-A611-2EE8EF79A35B

Q34800558-C71CF075-4D73-4D51-99DC-13D3A6C34235

Q34800558-DCC6BEBF-AD9D-468F-820E-8EBBE05F10A6

Q34800558-F3EF8312-9E30-4ECB-B7C1-06B204CFD9DF

Q34800558-F8BB532D-1704-417D-A69B-3D02331E0A40

P2860

Q34800558-03C24DA9-6723-4361-8332-7D9143A03CBE

Q34800558-0435F0BC-8E11-4677-ACB5-CE1A4A04A574

Q34800558-04C2245A-1159-4A0C-8A8A-AA15D0430762

Q34800558-069EB066-C111-40E6-AF25-F53CC37609FE

Q34800558-0C5FDBD2-8118-4387-B9E7-E0362EB6F0FD

Q34800558-0E6B5FA0-0830-4A4A-94E6-765A5D9542B6

Q34800558-0F398681-67C5-4EBF-9A0F-E50A2B6DFFA4

Q34800558-117A8515-07DB-4B26-9551-4921A3C63161

Q34800558-11F6FCDD-5437-450E-A27F-B35613C50308

Q34800558-12265F77-C7AE-4F95-9A22-DAAE3D1F6205

P304

Q34800558-79AD66DE-4C93-4142-A80E-6AAFECC1E51B

P31

Q34800558-EB875EE4-8409-4ABE-877E-2F704CD36BB2

P356

Q34800558-FCEA96BE-6CFD-4880-BD07-C0C4B2247427

P407

Q34800558-3B94EED9-8DB9-4E95-BECF-BE43D396D0CC

P433

Q34800558-8E465B6F-5C5D-4733-B896-780363D64B9E

P478

Q34800558-0D40375A-90A2-41F2-AFD9-45D2FBB1E94A

P577

Q34800558-7F54A425-29C2-4611-B5E5-D901BE0229A3

P698

Q34800558-14DC38D4-7373-47F5-8E4F-7853480ECA4C

P932

Q34800558-53385481-DFEC-4720-B0CE-6722E4712E8C

P356

JBC.M110.201061

P1433

Journal of Biological Chemistry

P1476

Hepatic FoxOs regulate lipid m ...... hosphoribosyltransferase gene.

@en

P2093

Dan Wei

http://www.w3.org/2001/XMLSchema#string

Hanlin Gao

http://www.w3.org/2001/XMLSchema#string

Ronald A DePinho

http://www.w3.org/2001/XMLSchema#string

Rongya Tao

http://www.w3.org/2001/XMLSchema#string

X Charlie Dong

http://www.w3.org/2001/XMLSchema#string

Yunlong Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation

Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2

SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme

Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase

APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function

Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production

P304

14681-14690

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M110.201061

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

286

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21388966

http://www.w3.org/2001/XMLSchema#string

P932

3077665

http://www.w3.org/2001/XMLSchema#string